1 suspended, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 1, Terminated 1 |
| Phase 1 | 1 | Suspended 1 |
Follow MetaPhore Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain M40403 - Cancer, Pain | Phase 2 | Terminated | MetaPhore Pharmaceuticals | 24 | 2004-08-01 | 2006-02-09 |
| Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2 M40403 - IL-2 Induced Hypotension | Phase 1 / Phase 2 | Suspended | MetaPhore Pharmaceuticals | 48 | 2001-12-01 | 2005-06-24 |
Carcinoma, Renal Cell (1) · Hypotension (1) · Melanoma (1) · Neoplasms (1) · Pain (1)
United States (1)